
    
      Study comparing intrasphincteric injection of AMDC-USR with placebo. Subjects unblinded after
      12 months visits, but followed for 2 years. Subjects randomized to placebo could elect to
      receive open-label AMDC-USR after completing 12 months visit.
    
  